These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35214781)

  • 1. Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia.
    AlRuthia Y; Al-Salloum HF; Almohammed OA; Alqahtani AS; Al-Abdulkarim HA; Alsofayan YM; Almudarra SS; AlQahtani SH; Almutlaq A; Alabdulkareem K; Balkhi B; Almutairi HT; Alanazi AS; Asiri YA
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile.
    Alzarea AI; Khan YH; Alatawi AD; Alanazi AS; Alzarea SI; Butt MH; Almalki ZS; Alahmari AK; Mallhi TH
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
    Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
    Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of COVID-19 Vaccines on Hospital Admission and Severity of Symptoms Among COVID-19 Patients in Saudi Arabia, 2021.
    Alnemari RF; Roublah FA; Bargawi AA
    Cureus; 2023 Jun; 15(6):e41067. PubMed ID: 37519611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.
    Bernardi FF; Mascolo A; Sarno M; Capoluongo N; Trama U; Ruggiero R; Sportiello L; Fusco GM; Bisogno M; Coscioni E; Iervolino A; Di Micco P; Capuano A; Perrella A
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study.
    Aldali J; Meo SA; Al-Khlaiwi T
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world effectiveness of COVID-19 vaccines: A retrospective cohort study of vaccinated individuals in Jazan, Saudi Arabia.
    Elamin MY; Maslamani YA; Muaddi MA; Alameer AA; Alqassim AY; Doweri AA; Zaylaee MM; Rayani HY; Darraj AY; Hejri YM; Dahlan AA; Gosadi IM
    J Infect Public Health; 2023 Sep; 16(9):1512-1517. PubMed ID: 37349242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.
    Meo SA; Shaikh N; Abukhalaf FA; Meo AS
    Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
    Eyre DW; Lumley SF; Wei J; Cox S; James T; Justice A; Jesuthasan G; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Jones EY; Stuart DI; Ebner D; Hoosdally S; Crook DW; Peto TEA; Walker TM; Stoesser NE; Matthews PC; Pouwels KB; Walker AS; Jeffery K
    Clin Microbiol Infect; 2021 Oct; 27(10):1516.e7-1516.e14. PubMed ID: 34111577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-COVID-19 Vaccination Infection Among Adults in Saudi Arabia: A Cross-Sectional Study.
    Mohammed RA; Baqais O; Basalib SG; Owaidah AA; Mirza A; Alharizi RM; Sultan I
    Cureus; 2023 Oct; 15(10):e47552. PubMed ID: 38021606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia.
    Farhat M; Al-Ibrahim R; Almohammedali A; Aljishi R; Alalwan B
    Int J Gen Med; 2022; 15():7547-7558. PubMed ID: 36196371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia.
    Adam M; Gameraddin M; Alelyani M; Alshahrani MY; Gareeballah A; Ahmad I; Azzawi A; Komit B; Musa A
    Patient Prefer Adherence; 2021; 15():1963-1970. PubMed ID: 34522089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study.
    Glampson B; Brittain J; Kaura A; Mulla A; Mercuri L; Brett SJ; Aylin P; Sandall T; Goodman I; Redhead J; Saravanakumar K; Mayer EK
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30010. PubMed ID: 34265740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of single and two-dose Pfizer-BioNTech vaccine against SARS-COV-2: A real-world evidence from Saudi Arabia.
    Albogami Y; Alalwan A; Batais MA; Alabdulkareem K; Alalwan AA
    J Infect Public Health; 2023 Dec; 16(12):1898-1903. PubMed ID: 37871358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum.
    Kaura A; Trickey A; Shah ASV; Benedetto U; Glampson B; Mulla A; Mercuri L; Gautama S; Costelloe CE; Goodman I; Redhead J; Saravanakumar K; Mayer E; Mayet J
    EClinicalMedicine; 2022 Apr; 46():101344. PubMed ID: 35295900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of self-reported adverse events related to COVID-19 vaccines in Saudi Arabia: A nationwide study.
    Alkhalifah JM; Al Seraihi A; Al-Tawfiq JA; Alshehri BF; Alhaluli AH; Alsulais NM; Alessa MM; Seddiq W; Aljeri T; Qahtani MH; Barry M; Al-Otaiby M
    Front Public Health; 2023; 11():1043696. PubMed ID: 36908451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.
    Alhazmi A; Alamer E; Daws D; Hakami M; Darraj M; Abdelwahab S; Maghfuri A; Algaissi A
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34207394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
    Majed SO
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.